Side Effects Assessment of High-Dose Cytosine Arabinoside Therapy for Children with Acute Leukemia or Lymphoma.
スポンサーリンク
概要
- 論文の詳細を見る
Seventy-five courses of high-dose cytosine arabinoside therapy (HD-CA) were administered to 36 children with leukemia or non-Hodgkin's lymphoma (NHL). Dose schedule of CA included 3 g/m<SUP>2</SUP> in one, 2 g/m<SUP>2</SUP> in 70, and 1.5 g/m<SUP>2</SUP> in 4 courses. Adverse reactions related to the HD-CA included transient and reversible marrow suppression (100%), vomiting (96%), drug-induced fever (51%), dermatitis (35%), conjunctivitis (21%), stomatitis (16%), diarrhea (13%), liver dysfunction (13%), meningeal irritation (4%), pulmonary toxicity (4%), anaphylactoid reaction (3%), cerebellar dysfunction (3%), and vasculitis (1%). However, no course was interrupted due to side effects. Evaluation of anticancer efficacy of the HD-CA regimen was not the primary target of this study, but four of the eight patients, who could not be induced into complete remission (CR) by alternate regimens, obtained CR after the HD-CA. The HD-CA appeared to be administered safely in children with leukemia or NHL.
- 特定非営利活動法人 日本小児血液・がん学会の論文
特定非営利活動法人 日本小児血液・がん学会 | 論文
- The Parent's Emotional Adaptation to the Children's Malignant Disease
- Side Effect of Cranial Radiation in Childhood Acute Leukemia
- Red Blood Cell Volume Distribution Width in Normal Children and in the Patients with Various Kinds of Hematological Disorders.
- Effective Conditioning of Donors for Granulocyte Transfusions with Recombinant Human Granulocyte Colony-Stimulating Factor.
- Two Infant Girls of CNS Leukemia with Chronic Subdural Hematoma